Literature DB >> 20300390

Histological diagnosis of madura foot (mycetoma): a must for definitive treatment.

Kiran Alam1, Veena Maheshwari, Shruti Bhargava, Anshu Jain, Uroos Fatima, Ershad Ul Haq.   

Abstract

Mycetoma, an uncommon chronic infection of skin and subcutaneous tissues in tropical countries is caused by true fungi (eumycetoma) or by filamentous bacteria (actinomycetoma). Since the treatment of these two etiologies is entirely different, a definite diagnosis after histopathological and microbiological examination is mandatory. We hereby present five cases of Madura foot.

Entities:  

Keywords:  Actinomycetoma; Eumycetoma; Madura foot

Year:  2009        PMID: 20300390      PMCID: PMC2840937          DOI: 10.4103/0974-777X.52985

Source DB:  PubMed          Journal:  J Glob Infect Dis        ISSN: 0974-777X


INTRODUCTION

Mycetoma is an uncommon chronic infective disease of the skin and subcutaneous tissues characterized by the triad of tumefaction, draining sinuses and presence of colonial grains in the exudates.[1-3] It is predominantly a disease of tropical countries and is named after the region of India where it was first described in 1842.[4] The most common site of occurrence is foot (approximately 70% cases), which explains the synonym “Madura foot”.[5] Hand is the next most common site. Repeated minor trauma or penetrating injury provides a portal of entry for the organism. Infection can be caused by true fungi in 40% cases where it is known as eumycetoma and by filamentous bacteria of order actinomycetes (actinomycetoma) in 60% cases.[4] Therapy of these two groups is entirely different,[6] thereby necessitating the need to differentiate between -the two in cases of patients presenting with Madura foot. Here we are describing five cases of Madura foot that were correctly diagnosed after detailed clinical, histopathological and microbiological studies.

CASE REPORT

Five male patients in the age range of 30-50 years presented in the surgical clinics with chief complaints of ulcer foot with purulent draining sinuses. Of the three patients presenting with ulcer, one showed features of healing [Figure 1]. The other two cases gave history of purulent discharge admixed with black granules. All patients belonged to rural backgrounds and had history of walking barefoot as necessitated by their occupational needs. Clinically all were diagnosed as Mycetoma foot or “Madura Foot”, and were advised biopsy along with culture of the purulent discharge. Crush smears of the discharged black granules were also prepared.
Figure 1

Madura foot-partially healed ulcer on the dorsal surface of ankle joint

Madura foot-partially healed ulcer on the dorsal surface of ankle joint Grams' staining was performed in all cases which helped in distinguishing between actinomycetoma (Gram positive) and eumycetoma (Gram negative). All these cases were subjected to biopsy. Grossly indurated skin with central ulceration surrounded by granulation tissue was received. On cut section subcutaneous abscess with multiloculations was seen. Histologically, H and E stain showed suppurative granulomas (composed of neutrophils) surrounding characteristic grains in the subcutaneous tissue. Neutrophilic infiltrate was seen surrounded by palisading histiocytes beyond which a mixed inflammatory infiltrate comprising lymphocytes, plasma cells, eosinophils, macrophages and fibrosis was seen. The occasional multinucleated giant cell was also seen [Figure 2]. H and E stained sections and Gram stain showed thin filamentous bacteria in cases of actinomycetoma [Figure 3] and thick club shaped structures in eumycetoma [Figure 4].
Figure 2

Actinomycetoma-neutrophilic infiltrate surrounding the actinomycotic colony with occasional giant cell (H and E, ×250)

Figure 3

Actinomycetoma-thin filamentous bacteria seen (H and E, ×500)

Figure 4

Eumycetoma-thick club shaped structures (<) (H and E, ×1250)

Actinomycetoma-neutrophilic infiltrate surrounding the actinomycotic colony with occasional giant cell (H and E, ×250) Actinomycetoma-thin filamentous bacteria seen (H and E, ×500) Eumycetoma-thick club shaped structures (<) (H and E, ×1250)

DISCUSSION

Mycetoma is endemic in the tropics and subtropics, namely Africa, Mexico and India, and is named after the region of India where it was first described in 1842.[4] However, it can also be found in natives of areas of Central and South America and the Middle or Far East between latitudes 15°S and 30°N. The incidence of mycetoma is likely to rise in temperate regions as well, due to increases in worldwide travel. It commonly presents between 20 to 50 years of age, with a male to female ratio of 2.2:1.[4] Mycetoma typically presents in agricultural workers or in individuals who walk barefoot in dry, dusty conditions. Minor trauma allows pathogens to enter the skin from the soil.[6] The two main etiological groups of mycetoma-actinomycetic mycetoma and eumycetic mycetoma are caused by a number of species. Over 30 species have been identified to cause mycetoma.[47] Actinomycetoma is caused by a group of filamentous bacteria, among which N. brasiliensis and Streptomyces madurae are the most common. In rare instances N. asteroides, commonly the cause of pulmonary nocardiosis and Actinomyces israelli, commonly the cause of Actinomyces produce a mycetoma on the feet or hands.[389] Eumycetoma is caused by a group of fungi with thick, septate hyphae, including Allescheria boydii, Madurella griesia and Madurella mycetomi.[9] The grains discharged from the sinuses vary in size, color and consistency [Tables 1 and 2], features that can be used for rapid provisional identification of the etiological agent. [4] Grains of many species have overlapping morphological features and therefore culture is required for accurate identification of the causal agent. The size of grains varies from microscopic to 1-2 mm in diameter. Large grains are seen with madurellae, Actinomadura madurae and A. palletieri whereas granules of N. brasiliensis, N. cavae and N. asteroides are small.[10] Dark (black) grains are found only among the eumycotic mycetoma. The pigment is a melanoprotein or related substance.[11] The consistency of most grains is soft but those of Streptomyces somaliensis and Madurella mycetomatis can be quite hard.[10]
Table 1

The color of the grains in mycetomas and related species

Color of grainsSpecies
Eumycetoma - black grainsM. mycetomatis, M. grisea, Leptospheria senegalensis, Exophiala jeanselmei, P. romeroi, C. lunata, Phialophora verrucosa, P. parasitica
Eumycetoma - pale grainsP. boydii, Aspergillus nidularis, A. flavus, Fusarium Sp, Acrimonium Sp, Neotestudina rosatii, dermatophytes
Actinomyetoma - red grainsActinomadura pelleitieri
Actinomycetoma - yellow grainsStreptomyces somaliensis
Actinomycetoma - pale grainsN. brasiliensis, N. cavae, N. asteroides, Actinomadura madurae
Table 2

Morphology of the grains in mycological and related species

SpeciesMorphology of grains
Eumycetomas
 Madurella mycetomatisLarge granules (up to 5 mm or more) with interlacing hyphae embedded in interstitial brownish matrix; hyphae at periphery arranged radially with numerous chlamydophores.
 Petriellidium boydiiEosinophilic, lighter in the centre; numerous vesicles or swollen hyphae; peripheral eosinophilic fringe; other pale eumycetomas have a minimal fringe and contain a dense mass of intermeshing hyphae.
Actinomycetomas
 Actinomadura maduraeLarge (1-5 mm and larger) and multilobulate; peripheral basophilia and central eosinophila or pale staining, filaments grow from the peripheral zone.
 Streptomyces somaliensisLarge 0.5-2 mm or more) with dense thin filaments; often stains homogenously; transverse fracture lines.
 Nocardia brasiliensisSmall grains (approximately 1 mm); central purple zone; loose clumps of filaments;
Gram positive delicate branching filaments breaking up into bacillary and coccal forms; Gram negative amorphous matrix.
The color of the grains in mycetomas and related species Morphology of the grains in mycological and related species The incubation period varies from several weeks to months.[4] Sinuses develop after 6-12 months and extension to involve the underlying fascia, muscle and bone is common. Rarely there is lymphatic dissemination to regional lymph nodes.[12] Actinomycetic mycetomas expand faster, are more invasive and have more sinuses than eumycotic variants.[4] A Gram stain is of considerable value in distinguishing between actinomycetoma and eumycetoma; the fine, branching filaments, only about 1 micron thick, within the grains of actinomycetoma are gram-positive, whereas the grains of eumycetoma are gram negative.[310] The filaments and hyphae of the causal agent can be stained better in biopsy samples with Gram stain (actinomycetoma) or Gomori methenamine silver or periodic acid-Schiff stains (eumycetoma). It can then be seen that the granules of actinomycetoma consist of fine, branching filaments, only about 1 micron thick, whereas the granules of eumycetoma are composed of septate hyphae 4-5 microns thick.[13] The study of discharged granules crushed on slide and stained with lacto-phenol blue particularly allows differentiation between the thin filaments of actinomycetoma and the thicker hyphae of eumycetoma.[3] Hence, these special stains are of value to further confirm the nature of the organism. It is important to let the lab know about the organism suspected because most bacterial pathogens grow out overnight but actinomycetes takes longer to be visible on the culture plates (48-72 hrs). There are no serological tests for specific diagnosis of the species.[9] In tropics this disease may go undiagnosed or untreated for so long that surgical amputation may be the only effective treatment. The main differential diagnoses are chronic bacterial osteomyelitis, tuberculosis, or the early phase of Buruli ulcer. Other deep fungal infections such as blastomycosis or coccidiodomycosis and also leishmaniasis, yaws and syphilis should be considered. Differentiation between actinomycetoma and eumycetoma is important because of the different responses to treatment. Surgical debridement, followed by prolonged appropriate antibiotic therapy for several months is required for actinomycetoma, wherein a combination therapy with trimethoprim-sulfamethoxazole, dapsone and streptomycin has been used along with Rifampicin for resistant cases.[14] Eumycetomas are only partially responsive to anti-fungal therapy but can be treated by surgery due to their normally well circumscribed nature. Surgery in combination with azole treatment is the recommended regime for small eumycetoma lesions in the extremities. Madurella mycetomatis may respond to ketoconazole; P. boydii (S. apiospermum) may respond to itraconazole. Other agents of eumycetoma may respond intermittently to itraconazole or amphotericin B.[15]

CONCLUSION

Due to slow and relatively pain free progression of the disease, mycetoma is often at an advanced stage when first diagnosed. Prognostically, actinomycetoma can be cured with surgical debridement and appropriate antibiotic therapy while eumycetoma is only partially responsive to antifungal agents, has high rate of recurrence and may require amputation. A high incidence of secondary bacterial infection in mycetoma lesions has been reported,[16] which can cause increased pain and disability as well as septicemia which may be fatal if untreated. This emphasizes the need for its correct diagnosis after meticulous clinical examination, assisted by histological and microbiological studies along with the use of special stains.
  15 in total

1.  Unexpected high prevalence of secondary bacterial infection in patients with mycetoma.

Authors:  A O Ahmed; E S Abugroun
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 2.  Mycetoma.

Authors:  R S Barnetson; L J Milne
Journal:  Br J Dermatol       Date:  1978-08       Impact factor: 9.302

Review 3.  Mycetoma.

Authors:  N Zaias; D Taplin; G Rebell
Journal:  Arch Dermatol       Date:  1969-02

Review 4.  Mycetoma : a review.

Authors:  Vanessa Lichon; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2006       Impact factor: 7.403

5.  Recurrent mycetoma of the foot.

Authors:  J D Davis; P A Stone; J J McGarry
Journal:  J Foot Ankle Surg       Date:  1999 Jan-Feb       Impact factor: 1.286

Review 6.  Management of mycetoma: major challenge in tropical mycoses with limited international recognition.

Authors:  Abdalla A O Ahmed; Wendy W J van de Sande; Ahmed Fahal; Irma Bakker-Woudenberg; Henri Verbrugh; Alex van Belkum
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

7.  [Madura's foot (mycetoma)].

Authors:  D Mercuţ; C Tiţa; G Ianoşi; Simona Ianoşi; Mihaela Tiţa
Journal:  Chirurgia (Bucur)       Date:  2003 May-Jun

Review 8.  Mycetoma: a thorn in the flesh.

Authors:  A H Fahal
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-01       Impact factor: 2.184

9.  Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.

Authors:  Wendy W J van de Sande; Johan de Kat; Jojanneke Coppens; Abdalla O A Ahmed; Ahmed Fahal; Henri Verbrugh; Alex van Belkum
Journal:  Microbes Infect       Date:  2007-05-18       Impact factor: 2.700

Review 10.  Nocardiosis causing pedal actinomycetoma: a case report and review of the literature.

Authors:  Carrie Gosselink; James Thomas; Sachin Brahmbhatt; Nilam K Patel; Jose Vindas
Journal:  J Foot Ankle Surg       Date:  2008 Sep-Oct       Impact factor: 1.286

View more
  10 in total

Review 1.  Madura foot: two case reports, review of the literature, and new developments with clinical correlation.

Authors:  Eric A White; Dakshesh B Patel; Deborah M Forrester; Christopher J Gottsegen; Emily O'Rourke; Paul Holtom; Timothy Charlton; George R Matcuk
Journal:  Skeletal Radiol       Date:  2013-10-23       Impact factor: 2.199

2.  An unusual cause of an ankle mass.

Authors:  Aditya Prinja; Catherine Roberts; Tom Doherty; Michael J Oddy
Journal:  BMJ Case Rep       Date:  2014-09-26

3.  Comment on "Orbital Actinomycetoma with cranial extension: A rare case report".

Authors:  Ali Beheshti Namdar; Saeed Sahebi; Masoud Keikha
Journal:  Int J Surg Case Rep       Date:  2022-06-25

4.  Rapid identification of black grain eumycetoma causative agents using rolling circle amplification.

Authors:  Sarah A Ahmed; Bert H G Gerrits van den Ende; Ahmed H Fahal; Wendy W J van de Sande; G S de Hoog
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

5.  Mapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling.

Authors:  Abdallah M Samy; Wendy W J van de Sande; Ahmed Hassan Fahal; A Townsend Peterson
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

6.  Chronic Madura foot: mycetoma and/or Actinomyces spp or actinomycosis.

Authors:  Abdulaziz Al Gannass
Journal:  BMJ Case Rep       Date:  2018-05-22

7.  The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents.

Authors:  Emmanuel Edwar Siddig; Najwa Adam Mhmoud; Sahar Mubarak Bakhiet; Omnia Babekir Abdallah; Salwa Osman Mekki; Nadia I El Dawi; Wendy Van de Sande; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2019-08-29

8.  Madura foot in a developed tropical country.

Authors:  Samuel S Y Wang
Journal:  Int J Infect Dis       Date:  2020-10-17       Impact factor: 3.623

Review 9.  Mycetoma: Development of Diagnosis and Treatment.

Authors:  Xingpei Hao; Marcus Cognetti; Rhonda Burch-Smith; Emerald O'Sullivan Mejia; Gene Mirkin
Journal:  J Fungi (Basel)       Date:  2022-07-19

10.  Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report.

Authors:  Arezki Izri; Mohanad Aljundi; Typhaine Billard-Pomares; Youssouf Fofana; Anthony Marteau; Theo Ghelfenstein Ferreira; Sophie Brun; Frederic Caux; Mohammad Akhoundi
Journal:  BMC Infect Dis       Date:  2020-11-11       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.